Morphometric analysis of oleic acid-induced permeability pulmonary edema: correlation with gravimetric lung water

Estabilidade do modelo animal de lesão pulmonar aguda induzida por ácido oleico

OBJETIVO: Avaliar a estabilidade das variáveis hemodinâmicas, da mecânica respiratória e de troca gasosa do modelo animal de lesão pulmonar aguda induzida por ácido oleico. MÉTODOS: Trata-se de um estudo experimental no qual foram utilizados 10 cães de raça indeterminada. As variáveis foram aferidas inicialmente e em 30, 60, 90 e 120 min após a administração do ácido oleico. Para analisar as medidas repetidas, foram testados efeitos lineares e quadráticos e foram utilizados ajustes de modelos lineares mistos com estruturas de variâncias e covariâncias diversificadas, dependendo da variável analisada. RESULTADOS: Observamos estabilidade da pressão arterial média aos 30 min, assim como da frequência cardíaca, da pressão arterial pulmonar e da pressão de capilar pulmonar aos 60 min. Frequência respiratória, volume corrente, volume minuto e trabalho respiratório estabilizaram aos 30 min. Quanto às variáveis de troca gasosa, PaO2, relação PaO2/FiO2 e fração de shunt pulmonar estabilizaram-se aos 30 min. As demais variáveis mantiveram-se em ascensão ou queda contínuas. CONCLUSÕES: O modelo de lesão pulmonar aguda induzida por ácido oleico é estável para algumas das variáveis testadas; porém, a estabilização se dá em momentos diferentes. As variáveis da mecânica respiratória e de troca gasosa estabilizaram em 30 min, e as hemodinâmicas, em 60 min.

Cationic liposomes as carriers for aerosolized formulations of an anionic drug: safety and efficacy study

This study tests the hypothesis that pegylated cationic liposomes are a viable carrier for inhalable formulations of low molecular weight heparin, an anionic drug. Cationic liposomal formulations of low molecular weight heparin were prepared by the hydration method using 1,2-dioleoyl-3-trimethylammonium-propane (chloride salt), cholesterol and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000]. The formulations were characterized for particle size, entrapment efficiency, pulmonary absorption and pharmacological efficacy. For absorption studies, the formulations were administered to anesthetized male Sprague-Dawley rats via the pulmonary route and drug absorption was monitored by measuring plasma anti-factor Xa activity. The pharmacological efficacy of the formulations was studied in rodent models of pulmonary embolism and deep vein thrombosis. The mean particle size of the liposomes was 104.8+/-20.7 nm and the drug entrapment efficiency was 90.3+/-0.1%. The half-life of the cationic liposomal formulation was 10.6+/-0.2h, a 2.2-fold increase compared to low molecular weight heparin formulated in saline, and the relative bioavailability was approximately 73.4+/-19.1% when compared to subcutaneously administered drug. A once-every-other-day inhaled dose of the formulation showed similar efficacy in reducing thrombus weight as a once-daily dose of subcutaneously administered drug. Likewise, cationic liposomal formulations administered via the pulmonary route 6h prior to embolization in the lungs showed a thrombolytic effect comparable to that of low molecular weight heparin administered subcutaneously 2h before embolization. Histological examination of lung tissue and measurement of injury markers in bronchoalveolar lavage fluid suggest that the formulations did not produce extensive damage. The results demonstrate that pegylated cationic liposomes could be a viable carrier for an inhalable formulation of low molecular weight heparin.

Relationship of interstitial fluid volume to alveolar fluid clearance in mice: ventilated vs. in situ studies

Our recent report (Garat C, Carter EP, and Matthay MA. J Appl Physiol 84: 1763-1767, 1998) described a new method to measure alveolar fluid clearance (AFC) in an in situ mouse preparation. However, in vivo preparations may be more suitable for studying alveolar fluid transport under some pathological conditions. Therefore, we developed a ventilated mouse model and compared AFC in the ventilated and the in situ mouse models. After 15 min, AFC was similar in both groups, but, after 30 min, AFC was 38% slower in the in situ mice (P < 0.05). Bilateral adrenalectomy and propranolol did not inhibit AFC after 15 min. Amiloride inhibited 90% of AFC in both groups. To evaluate the mechanism for the slower AFC in the in situ mouse preparation, we measured the extravascular lung water and calculated interstitial fluid volume. Extravascular lung water and interstitial fluid volume were greater in the in situ mice than in the ventilated mice at 30 min (P < 0.05). These results indicate that mouse AFC is fast, highly amiloride sensitive, and independent of endogenous catecholamines during the first 15 min. Accumulation of interstitial fluid probably plays an important role in slowing AFC in the in situ mouse lung model at later time intervals. These mouse models will be useful to quantify alveolar epithelial fluid transport under pathological conditions.